Kazia Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.

About KZIA

Kazia Therapeutics Ltd. is a clinical stage oncology company It engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia. 

CEO
James Stuart Garner
CEOJames Stuart Garner
Employees
—
Employees—
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1994
Founded1994
Employees
—
Employees—

KZIA Key Statistics

Market cap
10.13M
Market cap10.13M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
48.40K
Average volume48.40K
High today
$0.6499
High today$0.6499
Low today
$0.60
Low today$0.60
Open price
$0.625
Open price$0.625
Volume
118.98K
Volume118.98K
52 Week high
$8.90
52 Week high$8.90
52 Week low
$0.5551
52 Week low$0.5551

KZIA Earnings

Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
— per share
Estimated— per share
Actual
Expected Dec 16, Pre-Market
ActualExpected Dec 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.